Table 1 Preoperative clinical data
From: Minimally invasive and conventional surgical treatment of primary benign cardiac tumors
Characteristic | CMS group(n = 33) | RAMT group(n = 17) | P-value |
|---|---|---|---|
Age(y) | 54.45 ± 17.30 | 55.94 ± 18.24 | 0.752 |
Sex (female) | 19 (57.6%) | 12 (70.6%) | 0.369 |
Weight (kg) | 60.4 ± 15.7 | 54.1 ± 19.5 | 0.668 |
Patient history | 0.024 | ||
Acute (history <1w) | 3 (9.1%) | 6 (35.3%) | |
Subacute (1w – 1 m) | 6 (18.2%) | 0 (0.0%) | |
Chronic (history > 1 m) | 24 (72.7%) | 11 (64.7%) | |
Arrhythmia | 4 (12.1%) | 3 (17.6%) | 0.677 |
Preoperative stroke | 5 (15.2%) | 5 (29.4%) | 0.239 |
Fever | 2 (6.1%) | 0 (0.0%) | 0.542 |
Leukocyte increase | 1 (3.0%) | 1 (5.9%) | 1.000 |
Non-cardiac disease | 0.320 | ||
Hypertension | 4 (12.1%) | 4 (23.5%) | |
Hypertension and diabetes | 3 (9.1%) | 0 (0.0%) | |
Other diseases | 2 (6.1%) | 0 (0.0%) | |
Tumor site | 0.544 | ||
Left Atrium | 26 (78.8%) | 14 (82.4%) | |
Right Atrium | 5 (15.2%) | 3 (17.6%) | |
Left Ventricle | 1 (23.0%) | 0 (0.0%) | |
Right Ventricle | 1 (3.0%) | 0 (0.0%) | |
Aortic insufficiency | |||
Mild | 2 (6.1%) | 1 (5.9%) | 0.980 |
Mitral insufficiency | |||
Mild | 8 (24.2%) | 5 (29.4%) | 0.693 |
Tricuspid insufficiency | 0.197 | ||
Mild | 8 (24.2%) | 9 (52.9%) | |
Moderate | 3 (9.1%) | 1 (5.9%) | |
Severe | 2 (6.1%) | 0 (0.0%) | |
EF(%) | 61.1 ± 12.4 | 66.3 ± 4.6 | 0.386 |
FS(%) | 33.2 ± 7.3 | 36.6 ± 3.7 | 0.550 |
LVEDD (mm) | 45.5 ± 12.9 | 45.0 ± 6.8 | 0.319 |
LVESD (mm) | 29.9 ± 8.9 | 27.6 ± 4.9 | 0.402 |
Estimated pulmonary arterial systolic pressure (mmHg) | 23.4 ± 10.4 | 23.9 ± 6.2 | 0.586 |